EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
about
KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC)Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma.Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis.Anal squamous cell carcinoma: an evolution in disease and management.Anal cancer treatment: current status and future perspectives.Cetuximab in combination with cisplatin and 5-Fluorouracil induces dramatic response in metastatic refractory squamous cell carcinoma of the anal canal.Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection.Cancers of the anal canal: diagnosis, treatment and future strategies.EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection.HER3/ErbB3, an emerging cancer therapeutic target.Investigational drugs for treating anal cancer and future perspectives.Advances in the Management of Anal Cancer.Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer.Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial.No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC).Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.Survival rate variation with different histological subtypes of poor prognostic male anal squamous cell carcinoma: a population-based study.YKL-40 and EGFR is a good biomarker for predicting nodal metastasis in anal carcinoma.Background and Current Treatment of Squamous Cell Carcinoma of the Anus.KRAS and BRAF mutations in anal carcinoma.
P2860
Q28541078-FE9C6D37-7132-4AB1-90D2-A5DAF4C112E0Q33162775-E98F69C3-1115-4CBA-BEF2-386F79C65A5FQ33646367-F170D390-9F52-4E1B-B4D1-214F8274B3B0Q34255528-06A3DA36-EED5-4570-BE1B-DC7C88B3A33DQ34465769-82BEA309-8FA2-4AAF-AE78-8D25A2B5E3E2Q36062576-893C8B36-4154-4B02-BDFE-721D5B80AE18Q36244369-D98D2B3B-9B97-419E-B085-B72570933F59Q36685452-2225C369-FFD5-4A52-BE44-2B3A8C211F7EQ37174058-D1E2A8A6-CFB0-4DF8-B681-EFE684668EDAQ38232853-7DB00EBC-CBFF-46BB-90CE-2244194A17A8Q38552978-4B2EBCE9-913B-48FF-993D-BEEA3FA23532Q38615197-043A08AB-B210-4B4D-A9AC-043B871F00C3Q38631415-7E054BC7-648D-460A-9FFC-340DF7DC391DQ38746232-5359E327-4694-4965-8B4A-DADA6838D311Q38996898-01D08A59-C00C-4F9B-8901-3A00BCFAB8A3Q39020800-60183329-D476-4267-A3FE-58374CCAFBAEQ39034562-C2D76FDF-3D90-4CDA-B15A-DE0A2AD624A5Q39154481-011FBBAE-DBAA-41B6-ADE9-1C2BC01E26C4Q40814170-C042BF1D-A9DE-4967-964F-3D94AE55B5A2Q44990570-FAEBD897-007A-4970-B2DB-C878432F2252Q47985517-1221F316-CF33-443E-8446-C76A18283845Q50897271-3B4960F2-04F2-4B01-B135-99507442CF73Q55071072-8B5CC5C9-1D45-476A-AC7A-42F7B28224A5
P2860
EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
EGFR and K-ras gene mutation s ...... radiation and EGFR inhibitors?
@ast
EGFR and K-ras gene mutation s ...... radiation and EGFR inhibitors?
@en
type
label
EGFR and K-ras gene mutation s ...... radiation and EGFR inhibitors?
@ast
EGFR and K-ras gene mutation s ...... radiation and EGFR inhibitors?
@en
prefLabel
EGFR and K-ras gene mutation s ...... radiation and EGFR inhibitors?
@ast
EGFR and K-ras gene mutation s ...... radiation and EGFR inhibitors?
@en
P2093
P2860
P356
P1476
EGFR and K-ras gene mutation s ...... radiation and EGFR inhibitors?
@en
P2093
R Onerheim
T Alcindor
P2860
P2888
P304
P356
10.1038/BJC.2012.479
P407
P577
2012-10-23T00:00:00Z